Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
Short-term, they're useful
Continue the same injection frequency and rotation schedule
Preclinical evidence supports BPC-157s ability to: Heal gastric and intestinal ulcers Restore tight junction integrity in leaky gut models Protect against NSAID- and alcohol-induced GI damage Modulate inflammatory responses in colitis and Crohns Support microvascular circulation and enteric nerve health Across nearly all models of gastrointestinal injury, BPC-157 promoted effective healing without toxicity, making it one of the most promising peptides for gut repair. Sikiric, P
In the Phase 2 clinical trial (NEJM, 2023), retatrutide was administered subcutaneously at doses ranging from approximately 0.5 mg to 12 mg per week, with dose escalation under close medical supervision
US$ 21.91
US$ 20.18
US$ 20.81
US$ 25.07
US$ 22.91
US$ 21.87
US$ 27.15
US$ 22.24
US$ 23.95
US$ 23.18
US$ 20.87